EPITOPE SUMMARY | |
---|---|
6-[(1,4-dideoxy-D-ribityl)amino]-5-[(E)-(2-oxopropylidene)amino]uracil (epitope ID ) has this structure: . The epitope has these synonyms: 1,4-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol, 1,4-dideoxy-1-[[1,2,3,6-tetrahydro-2,6-dioxo-5-[[(1E)-2-oxopropylidene]amino]-4-pyrimidinyl]amino]-D-erythro-pentitol, 4'-D-5-OP-RU, 6-[(1,4-dideoxy-D-ribityl)amino]-5-[(E)-(2-oxopropylidene)amino]uracil. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, MHC ligand assays and has 3D structure(s) . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
human MR1 | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
dissociation constant KD | / |
3D structure | / |
activation | / |
IFNg release | / |
qualitative binding | / |
TNF release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |